Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug;34(4):285-98.
doi: 10.1023/a:1020256502583.

Opening of mitochondrial K+ channels increases ischemic ATP levels by preventing hydrolysis

Affiliations

Opening of mitochondrial K+ channels increases ischemic ATP levels by preventing hydrolysis

Eduardo Belisle et al. J Bioenerg Biomembr. 2002 Aug.

Abstract

Mitochondrial ATP-sensitive K+ channels (mitoK(ATP)) have been proposed to mediate protection against ischemic injury by increasing high-energy intermediate levels. This study was designed to verify if mitochondria are an important factor in the loss of cardiac ATP associated to ischemia, and determine the possible role of mitoK(ATP) in the control of ischemic ATP loss. Langendorff-perfused rat hearts subjected to ischemia were found to have significantly higher ATP contents when pretreated with oligomycin or atractyloside, indicating that mitochondrial ATP hydrolysis contributes toward ischemic ATP depletion. MitoK(ATP) opening induced by diazoxide promoted a similar protection against ATP loss. Diazoxide also inhibited ATP hydrolysis in isolated, nonrespiring mitochondria, an effect accompanied by a drop in the membrane potential and Ca2+ uptake. In hearts subjected to ischemia followed by reperfusion, myocardial injury was prevented by diazoxide, but not atractyloside or oligomycin, which, unlike diazoxide, decreased reperfusion ATP levels. Our results suggest that mitoK(ATP)-mediated protection occurs due to selective inhibition of mitochondrial ATP hydrolysis during ischemia, without affecting ATP synthesis after reperfusion.

PubMed Disclaimer

References

    1. Circ Res. 2001 Nov 9;89(10):856-8 - PubMed
    1. Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1278-85 - PubMed
    1. Biofactors. 1998;8(3-4):235-42 - PubMed
    1. J Mol Cell Cardiol. 2001 May;33(5):947-56 - PubMed
    1. FEBS Lett. 1976 Oct 1;68(2):191-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources